 | • レポートコード：MRC2-11QY02580 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は抗腫瘍剤のグローバル市場について調査・分析したレポートです。種類別（化学療法剤、生物学的/免疫療法剤、個別化医療）市場規模、用途別（病院、診療所、がんリハビリセンター、外来外科センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別抗腫瘍剤の競争状況、市場シェア ・世界の抗腫瘍剤市場：種類別市場規模 2015年-2020年（化学療法剤、生物学的/免疫療法剤、個別化医療） ・世界の抗腫瘍剤市場：種類別市場規模予測 2021年-2026年（化学療法剤、生物学的/免疫療法剤、個別化医療） ・世界の抗腫瘍剤市場：用途別市場規模 2015年-2020年（病院、診療所、がんリハビリセンター、外来外科センター） ・世界の抗腫瘍剤市場：用途別市場規模予測 2021年-2026年（病院、診療所、がんリハビリセンター、外来外科センター） ・北米の抗腫瘍剤市場分析：米国、カナダ ・ヨーロッパの抗腫瘍剤市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの抗腫瘍剤市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の抗腫瘍剤市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの抗腫瘍剤市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Hoffmann-La Roche、Amgen、Bristol-Myers Squibb Company、Baxter、Boehringer Ingelheim、Bayer、Teva pharmaceutical Industries、Johnson & Johnson、Merck、Pfize、Accord Healthcare、Lundbeck、AbbVie ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Antineoplastic is a class of medicine to restrain or kill tumor cells in the body. It plays an important role in comprehensive cancer treatment, particularly for disseminated tumor and leukemia that cannot be treated with surgery. Most current antineoplastics work by inhibiting DNA or RNA synthesis, or even damaging the structure of DNA. Antineoplastics can be divided into CCNSA (Cell cycle nonspecific drug) and CCSA (Cell Cycle Specific agents) according to their different effect on tumor cells in different stages of generation cycles. Both of them have a killing effect on bone marrow hematopoietic stem cells and other cells with a short growth cycle, as well as an inhibiting effect on the body’s immune response.
Factors such as growing incidence of cancer across the globe and demand for cost-effective treatment options are believed to play crucial role for the growth of global anti-neoplastic agents market. Rapid innovation in the field of personalized medicine presents a huge opportunity to manufacturers of anti-neoplastic agents. However, heterogeneous nature of cancer and high development cost of neoplastic agents are the factors limiting the growth of global anti-neoplastic agents market.
Market Analysis and Insights: Global Anti-Neoplastic Agents Market
The global Anti-Neoplastic Agents market size is projected to reach US$ 119390 million by 2026, from US$ 113810 million in 2020, at a CAGR of 4.5%% during 2021-2026.
Global Anti-Neoplastic Agents Scope and Market Size
Anti-Neoplastic Agents market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Neoplastic Agents market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Anti-Neoplastic Agents market is segmented into
Chemotherapeutic Agents
Biological/Immunotherapeutic Agents
Personalized Medicine
Segment by Application, the Anti-Neoplastic Agents market is segmented into
Hospitals
Clinics
Cancer Rehabilitation Centers
Ambulatory Surgical Centers
Regional and Country-level Analysis
The Anti-Neoplastic Agents market is analysed and market size information is provided by regions (countries).
The key regions covered in the Anti-Neoplastic Agents market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Anti-Neoplastic Agents Market Share Analysis
Anti-Neoplastic Agents market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Anti-Neoplastic Agents business, the date to enter into the Anti-Neoplastic Agents market, Anti-Neoplastic Agents product introduction, recent developments, etc.
The major vendors covered:
Hoffmann-La Roche
Amgen
Bristol-Myers Squibb Company
Baxter
Boehringer Ingelheim
Bayer
Teva pharmaceutical Industries
Johnson & Johnson
Merck
Pfize
Accord Healthcare
Lundbeck
AbbVie
1 Study Coverage
1.1 Anti-Neoplastic Agents Product Introduction
1.2 Market Segments
1.3 Key Anti-Neoplastic Agents Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Anti-Neoplastic Agents Market Size Growth Rate by Type
1.4.2 Chemotherapeutic Agents
1.4.3 Biological/Immunotherapeutic Agents
1.4.4 Personalized Medicine
1.5 Market by Application
1.5.1 Global Anti-Neoplastic Agents Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Cancer Rehabilitation Centers
1.5.5 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Anti-Neoplastic Agents Market Size, Estimates and Forecasts
2.1.1 Global Anti-Neoplastic Agents Revenue 2015-2026
2.1.2 Global Anti-Neoplastic Agents Sales 2015-2026
2.2 Global Anti-Neoplastic Agents, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Anti-Neoplastic Agents Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Anti-Neoplastic Agents Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Anti-Neoplastic Agents Competitor Landscape by Players
3.1 Anti-Neoplastic Agents Sales by Manufacturers
3.1.1 Anti-Neoplastic Agents Sales by Manufacturers (2015-2020)
3.1.2 Anti-Neoplastic Agents Sales Market Share by Manufacturers (2015-2020)
3.2 Anti-Neoplastic Agents Revenue by Manufacturers
3.2.1 Anti-Neoplastic Agents Revenue by Manufacturers (2015-2020)
3.2.2 Anti-Neoplastic Agents Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Anti-Neoplastic Agents Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Anti-Neoplastic Agents Revenue in 2019
3.2.5 Global Anti-Neoplastic Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Anti-Neoplastic Agents Price by Manufacturers
3.4 Anti-Neoplastic Agents Manufacturing Base Distribution, Product Types
3.4.1 Anti-Neoplastic Agents Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Anti-Neoplastic Agents Product Type
3.4.3 Date of International Manufacturers Enter into Anti-Neoplastic Agents Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Anti-Neoplastic Agents Market Size by Type (2015-2020)
4.1.1 Global Anti-Neoplastic Agents Sales by Type (2015-2020)
4.1.2 Global Anti-Neoplastic Agents Revenue by Type (2015-2020)
4.1.3 Anti-Neoplastic Agents Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Anti-Neoplastic Agents Market Size Forecast by Type (2021-2026)
4.2.1 Global Anti-Neoplastic Agents Sales Forecast by Type (2021-2026)
4.2.2 Global Anti-Neoplastic Agents Revenue Forecast by Type (2021-2026)
4.2.3 Anti-Neoplastic Agents Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Anti-Neoplastic Agents Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Anti-Neoplastic Agents Market Size by Application (2015-2020)
5.1.1 Global Anti-Neoplastic Agents Sales by Application (2015-2020)
5.1.2 Global Anti-Neoplastic Agents Revenue by Application (2015-2020)
5.1.3 Anti-Neoplastic Agents Price by Application (2015-2020)
5.2 Anti-Neoplastic Agents Market Size Forecast by Application (2021-2026)
5.2.1 Global Anti-Neoplastic Agents Sales Forecast by Application (2021-2026)
5.2.2 Global Anti-Neoplastic Agents Revenue Forecast by Application (2021-2026)
5.2.3 Global Anti-Neoplastic Agents Price Forecast by Application (2021-2026)
6 North America
6.1 North America Anti-Neoplastic Agents by Country
6.1.1 North America Anti-Neoplastic Agents Sales by Country
6.1.2 North America Anti-Neoplastic Agents Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Anti-Neoplastic Agents Market Facts & Figures by Type
6.3 North America Anti-Neoplastic Agents Market Facts & Figures by Application
7 Europe
7.1 Europe Anti-Neoplastic Agents by Country
7.1.1 Europe Anti-Neoplastic Agents Sales by Country
7.1.2 Europe Anti-Neoplastic Agents Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Anti-Neoplastic Agents Market Facts & Figures by Type
7.3 Europe Anti-Neoplastic Agents Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Anti-Neoplastic Agents by Region
8.1.1 Asia Pacific Anti-Neoplastic Agents Sales by Region
8.1.2 Asia Pacific Anti-Neoplastic Agents Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Anti-Neoplastic Agents Market Facts & Figures by Type
8.3 Asia Pacific Anti-Neoplastic Agents Market Facts & Figures by Application
9 Latin America
9.1 Latin America Anti-Neoplastic Agents by Country
9.1.1 Latin America Anti-Neoplastic Agents Sales by Country
9.1.2 Latin America Anti-Neoplastic Agents Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Anti-Neoplastic Agents Market Facts & Figures by Type
9.3 Central & South America Anti-Neoplastic Agents Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Anti-Neoplastic Agents by Country
10.1.1 Middle East and Africa Anti-Neoplastic Agents Sales by Country
10.1.2 Middle East and Africa Anti-Neoplastic Agents Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Anti-Neoplastic Agents Market Facts & Figures by Type
10.3 Middle East and Africa Anti-Neoplastic Agents Market Facts & Figures by Application
11 Company Profiles
11.1 Hoffmann-La Roche
11.1.1 Hoffmann-La Roche Corporation Information
11.1.2 Hoffmann-La Roche Description and Business Overview
11.1.3 Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Hoffmann-La Roche Anti-Neoplastic Agents Products Offered
11.1.5 Hoffmann-La Roche Related Developments
11.2 Amgen
11.2.1 Amgen Corporation Information
11.2.2 Amgen Description and Business Overview
11.2.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Amgen Anti-Neoplastic Agents Products Offered
11.2.5 Amgen Related Developments
11.3 Bristol-Myers Squibb Company
11.3.1 Bristol-Myers Squibb Company Corporation Information
11.3.2 Bristol-Myers Squibb Company Description and Business Overview
11.3.3 Bristol-Myers Squibb Company Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Bristol-Myers Squibb Company Anti-Neoplastic Agents Products Offered
11.3.5 Bristol-Myers Squibb Company Related Developments
11.4 Baxter
11.4.1 Baxter Corporation Information
11.4.2 Baxter Description and Business Overview
11.4.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Baxter Anti-Neoplastic Agents Products Offered
11.4.5 Baxter Related Developments
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Corporation Information
11.5.2 Boehringer Ingelheim Description and Business Overview
11.5.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Boehringer Ingelheim Anti-Neoplastic Agents Products Offered
11.5.5 Boehringer Ingelheim Related Developments
11.6 Bayer
11.6.1 Bayer Corporation Information
11.6.2 Bayer Description and Business Overview
11.6.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Bayer Anti-Neoplastic Agents Products Offered
11.6.5 Bayer Related Developments
11.7 Teva pharmaceutical Industries
11.7.1 Teva pharmaceutical Industries Corporation Information
11.7.2 Teva pharmaceutical Industries Description and Business Overview
11.7.3 Teva pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Teva pharmaceutical Industries Anti-Neoplastic Agents Products Offered
11.7.5 Teva pharmaceutical Industries Related Developments
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Corporation Information
11.8.2 Johnson & Johnson Description and Business Overview
11.8.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Johnson & Johnson Anti-Neoplastic Agents Products Offered
11.8.5 Johnson & Johnson Related Developments
11.9 Merck
11.9.1 Merck Corporation Information
11.9.2 Merck Description and Business Overview
11.9.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Merck Anti-Neoplastic Agents Products Offered
11.9.5 Merck Related Developments
11.10 Pfize
11.10.1 Pfize Corporation Information
11.10.2 Pfize Description and Business Overview
11.10.3 Pfize Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Pfize Anti-Neoplastic Agents Products Offered
11.10.5 Pfize Related Developments
11.1 Hoffmann-La Roche
11.1.1 Hoffmann-La Roche Corporation Information
11.1.2 Hoffmann-La Roche Description and Business Overview
11.1.3 Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Hoffmann-La Roche Anti-Neoplastic Agents Products Offered
11.1.5 Hoffmann-La Roche Related Developments
11.12 Lundbeck
11.12.1 Lundbeck Corporation Information
11.12.2 Lundbeck Description and Business Overview
11.12.3 Lundbeck Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Lundbeck Products Offered
11.12.5 Lundbeck Related Developments
11.13 AbbVie
11.13.1 AbbVie Corporation Information
11.13.2 AbbVie Description and Business Overview
11.13.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
11.13.4 AbbVie Products Offered
11.13.5 AbbVie Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Anti-Neoplastic Agents Market Estimates and Projections by Region
12.1.1 Global Anti-Neoplastic Agents Sales Forecast by Regions 2021-2026
12.1.2 Global Anti-Neoplastic Agents Revenue Forecast by Regions 2021-2026
12.2 North America Anti-Neoplastic Agents Market Size Forecast (2021-2026)
12.2.1 North America: Anti-Neoplastic Agents Sales Forecast (2021-2026)
12.2.2 North America: Anti-Neoplastic Agents Revenue Forecast (2021-2026)
12.2.3 North America: Anti-Neoplastic Agents Market Size Forecast by Country (2021-2026)
12.3 Europe Anti-Neoplastic Agents Market Size Forecast (2021-2026)
12.3.1 Europe: Anti-Neoplastic Agents Sales Forecast (2021-2026)
12.3.2 Europe: Anti-Neoplastic Agents Revenue Forecast (2021-2026)
12.3.3 Europe: Anti-Neoplastic Agents Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Anti-Neoplastic Agents Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Anti-Neoplastic Agents Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Anti-Neoplastic Agents Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Anti-Neoplastic Agents Market Size Forecast by Region (2021-2026)
12.5 Latin America Anti-Neoplastic Agents Market Size Forecast (2021-2026)
12.5.1 Latin America: Anti-Neoplastic Agents Sales Forecast (2021-2026)
12.5.2 Latin America: Anti-Neoplastic Agents Revenue Forecast (2021-2026)
12.5.3 Latin America: Anti-Neoplastic Agents Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Anti-Neoplastic Agents Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Anti-Neoplastic Agents Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Anti-Neoplastic Agents Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Anti-Neoplastic Agents Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Anti-Neoplastic Agents Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Anti-Neoplastic Agents Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Anti-Neoplastic Agents Market Segments
Table 2. Ranking of Global Top Anti-Neoplastic Agents Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Anti-Neoplastic Agents Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Chemotherapeutic Agents
Table 5. Major Manufacturers of Biological/Immunotherapeutic Agents
Table 6. Major Manufacturers of Personalized Medicine
Table 7. Global Anti-Neoplastic Agents Market Size Growth Rate by Application 2020-2026 (K MT)
Table 8. Global Anti-Neoplastic Agents Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 9. Global Anti-Neoplastic Agents Sales by Regions 2015-2020 (K MT)
Table 10. Global Anti-Neoplastic Agents Sales Market Share by Regions (2015-2020)
Table 11. Global Anti-Neoplastic Agents Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Anti-Neoplastic Agents Sales by Manufacturers (2015-2020) (K MT)
Table 13. Global Anti-Neoplastic Agents Sales Share by Manufacturers (2015-2020)
Table 14. Global Anti-Neoplastic Agents Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Anti-Neoplastic Agents by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Neoplastic Agents as of 2019)
Table 16. Anti-Neoplastic Agents Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Anti-Neoplastic Agents Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Anti-Neoplastic Agents Price (2015-2020) (USD/MT)
Table 19. Anti-Neoplastic Agents Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Anti-Neoplastic Agents Product Type
Table 21. Date of International Manufacturers Enter into Anti-Neoplastic Agents Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Anti-Neoplastic Agents Sales by Type (2015-2020) (K MT)
Table 24. Global Anti-Neoplastic Agents Sales Share by Type (2015-2020)
Table 25. Global Anti-Neoplastic Agents Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Anti-Neoplastic Agents Revenue Share by Type (2015-2020)
Table 27. Anti-Neoplastic Agents Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 28. Global Anti-Neoplastic Agents Sales by Application (2015-2020) (K MT)
Table 29. Global Anti-Neoplastic Agents Sales Share by Application (2015-2020)
Table 30. North America Anti-Neoplastic Agents Sales by Country (2015-2020) (K MT)
Table 31. North America Anti-Neoplastic Agents Sales Market Share by Country (2015-2020)
Table 32. North America Anti-Neoplastic Agents Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Anti-Neoplastic Agents Revenue Market Share by Country (2015-2020)
Table 34. North America Anti-Neoplastic Agents Sales by Type (2015-2020) (K MT)
Table 35. North America Anti-Neoplastic Agents Sales Market Share by Type (2015-2020)
Table 36. North America Anti-Neoplastic Agents Sales by Application (2015-2020) (K MT)
Table 37. North America Anti-Neoplastic Agents Sales Market Share by Application (2015-2020)
Table 38. Europe Anti-Neoplastic Agents Sales by Country (2015-2020) (K MT)
Table 39. Europe Anti-Neoplastic Agents Sales Market Share by Country (2015-2020)
Table 40. Europe Anti-Neoplastic Agents Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Anti-Neoplastic Agents Revenue Market Share by Country (2015-2020)
Table 42. Europe Anti-Neoplastic Agents Sales by Type (2015-2020) (K MT)
Table 43. Europe Anti-Neoplastic Agents Sales Market Share by Type (2015-2020)
Table 44. Europe Anti-Neoplastic Agents Sales by Application (2015-2020) (K MT)
Table 45. Europe Anti-Neoplastic Agents Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Anti-Neoplastic Agents Sales by Region (2015-2020) (K MT)
Table 47. Asia Pacific Anti-Neoplastic Agents Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Anti-Neoplastic Agents Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Anti-Neoplastic Agents Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Anti-Neoplastic Agents Sales by Type (2015-2020) (K MT)
Table 51. Asia Pacific Anti-Neoplastic Agents Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Anti-Neoplastic Agents Sales by Application (2015-2020) (K MT)
Table 53. Asia Pacific Anti-Neoplastic Agents Sales Market Share by Application (2015-2020)
Table 54. Latin America Anti-Neoplastic Agents Sales by Country (2015-2020) (K MT)
Table 55. Latin America Anti-Neoplastic Agents Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Anti-Neoplastic Agents Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Anti-Neoplastic Agents Revenue Market Share by Country (2015-2020)
Table 58. Latin America Anti-Neoplastic Agents Sales by Type (2015-2020) (K MT)
Table 59. Latin America Anti-Neoplastic Agents Sales Market Share by Type (2015-2020)
Table 60. Latin America Anti-Neoplastic Agents Sales by Application (2015-2020) (K MT)
Table 61. Latin America Anti-Neoplastic Agents Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Anti-Neoplastic Agents Sales by Country (2015-2020) (K MT)
Table 63. Middle East and Africa Anti-Neoplastic Agents Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Anti-Neoplastic Agents Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Anti-Neoplastic Agents Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Anti-Neoplastic Agents Sales by Type (2015-2020) (K MT)
Table 67. Middle East and Africa Anti-Neoplastic Agents Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Anti-Neoplastic Agents Sales by Application (2015-2020) (K MT)
Table 69. Middle East and Africa Anti-Neoplastic Agents Sales Market Share by Application (2015-2020)
Table 70. Hoffmann-La Roche Corporation Information
Table 71. Hoffmann-La Roche Description and Major Businesses
Table 72. Hoffmann-La Roche Anti-Neoplastic Agents Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 73. Hoffmann-La Roche Product
Table 74. Hoffmann-La Roche Recent Development
Table 75. Amgen Corporation Information
Table 76. Amgen Description and Major Businesses
Table 77. Amgen Anti-Neoplastic Agents Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Amgen Product
Table 79. Amgen Recent Development
Table 80. Bristol-Myers Squibb Company Corporation Information
Table 81. Bristol-Myers Squibb Company Description and Major Businesses
Table 82. Bristol-Myers Squibb Company Anti-Neoplastic Agents Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Bristol-Myers Squibb Company Product
Table 84. Bristol-Myers Squibb Company Recent Development
Table 85. Baxter Corporation Information
Table 86. Baxter Description and Major Businesses
Table 87. Baxter Anti-Neoplastic Agents Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Baxter Product
Table 89. Baxter Recent Development
Table 90. Boehringer Ingelheim Corporation Information
Table 91. Boehringer Ingelheim Description and Major Businesses
Table 92. Boehringer Ingelheim Anti-Neoplastic Agents Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Boehringer Ingelheim Product
Table 94. Boehringer Ingelheim Recent Development
Table 95. Bayer Corporation Information
Table 96. Bayer Description and Major Businesses
Table 97. Bayer Anti-Neoplastic Agents Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Bayer Product
Table 99. Bayer Recent Development
Table 100. Teva pharmaceutical Industries Corporation Information
Table 101. Teva pharmaceutical Industries Description and Major Businesses
Table 102. Teva pharmaceutical Industries Anti-Neoplastic Agents Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Teva pharmaceutical Industries Product
Table 104. Teva pharmaceutical Industries Recent Development
Table 105. Johnson & Johnson Corporation Information
Table 106. Johnson & Johnson Description and Major Businesses
Table 107. Johnson & Johnson Anti-Neoplastic Agents Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Johnson & Johnson Product
Table 109. Johnson & Johnson Recent Development
Table 110. Merck Corporation Information
Table 111. Merck Description and Major Businesses
Table 112. Merck Anti-Neoplastic Agents Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. Merck Product
Table 114. Merck Recent Development
Table 115. Pfize Corporation Information
Table 116. Pfize Description and Major Businesses
Table 117. Pfize Anti-Neoplastic Agents Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 118. Pfize Product
Table 119. Pfize Recent Development
Table 120. Accord Healthcare Corporation Information
Table 121. Accord Healthcare Description and Major Businesses
Table 122. Accord Healthcare Anti-Neoplastic Agents Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Accord Healthcare Product
Table 124. Accord Healthcare Recent Development
Table 125. Lundbeck Corporation Information
Table 126. Lundbeck Description and Major Businesses
Table 127. Lundbeck Anti-Neoplastic Agents Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Lundbeck Product
Table 129. Lundbeck Recent Development
Table 130. AbbVie Corporation Information
Table 131. AbbVie Description and Major Businesses
Table 132. AbbVie Anti-Neoplastic Agents Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. AbbVie Product
Table 134. AbbVie Recent Development
Table 135. Global Anti-Neoplastic Agents Sales Forecast by Regions (2021-2026) (K MT)
Table 136. Global Anti-Neoplastic Agents Sales Market Share Forecast by Regions (2021-2026)
Table 137. Global Anti-Neoplastic Agents Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 138. Global Anti-Neoplastic Agents Revenue Market Share Forecast by Regions (2021-2026)
Table 139. North America: Anti-Neoplastic Agents Sales Forecast by Country (2021-2026) (K MT)
Table 140. North America: Anti-Neoplastic Agents Revenue Forecast by Country (2021-2026) (US$ Million)
Table 141. Europe: Anti-Neoplastic Agents Sales Forecast by Country (2021-2026) (K MT)
Table 142. Europe: Anti-Neoplastic Agents Revenue Forecast by Country (2021-2026) (US$ Million)
Table 143. Asia Pacific: Anti-Neoplastic Agents Sales Forecast by Region (2021-2026) (K MT)
Table 144. Asia Pacific: Anti-Neoplastic Agents Revenue Forecast by Region (2021-2026) (US$ Million)
Table 145. Latin America: Anti-Neoplastic Agents Sales Forecast by Country (2021-2026) (K MT)
Table 146. Latin America: Anti-Neoplastic Agents Revenue Forecast by Country (2021-2026) (US$ Million)
Table 147. Middle East and Africa: Anti-Neoplastic Agents Sales Forecast by Country (2021-2026) (K MT)
Table 148. Middle East and Africa: Anti-Neoplastic Agents Revenue Forecast by Country (2021-2026) (US$ Million)
Table 149. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 150. Key Challenges
Table 151. Market Risks
Table 152. Main Points Interviewed from Key Anti-Neoplastic Agents Players
Table 153. Anti-Neoplastic Agents Customers List
Table 154. Anti-Neoplastic Agents Distributors List
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-Neoplastic Agents Product Picture
Figure 2. Global Anti-Neoplastic Agents Sales Market Share by Type in 2020 & 2026
Figure 3. Chemotherapeutic Agents Product Picture
Figure 4. Biological/Immunotherapeutic Agents Product Picture
Figure 5. Personalized Medicine Product Picture
Figure 6. Global Anti-Neoplastic Agents Sales Market Share by Application in 2020 & 2026
Figure 7. Hospitals
Figure 8. Clinics
Figure 9. Cancer Rehabilitation Centers
Figure 10. Ambulatory Surgical Centers
Figure 11. Anti-Neoplastic Agents Report Years Considered
Figure 12. Global Anti-Neoplastic Agents Market Size 2015-2026 (US$ Million)
Figure 13. Global Anti-Neoplastic Agents Sales 2015-2026 (K MT)
Figure 14. Global Anti-Neoplastic Agents Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Anti-Neoplastic Agents Sales Market Share by Region (2015-2020)
Figure 16. Global Anti-Neoplastic Agents Sales Market Share by Region in 2019
Figure 17. Global Anti-Neoplastic Agents Revenue Market Share by Region (2015-2020)
Figure 18. Global Anti-Neoplastic Agents Revenue Market Share by Region in 2019
Figure 19. Global Anti-Neoplastic Agents Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Anti-Neoplastic Agents Revenue in 2019
Figure 21. Anti-Neoplastic Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Anti-Neoplastic Agents Sales Market Share by Type (2015-2020)
Figure 23. Global Anti-Neoplastic Agents Sales Market Share by Type in 2019
Figure 24. Global Anti-Neoplastic Agents Revenue Market Share by Type (2015-2020)
Figure 25. Global Anti-Neoplastic Agents Revenue Market Share by Type in 2019
Figure 26. Global Anti-Neoplastic Agents Market Share by Price Range (2015-2020)
Figure 27. Global Anti-Neoplastic Agents Sales Market Share by Application (2015-2020)
Figure 28. Global Anti-Neoplastic Agents Sales Market Share by Application in 2019
Figure 29. Global Anti-Neoplastic Agents Revenue Market Share by Application (2015-2020)
Figure 30. Global Anti-Neoplastic Agents Revenue Market Share by Application in 2019
Figure 31. North America Anti-Neoplastic Agents Sales Growth Rate 2015-2020 (K MT)
Figure 32. North America Anti-Neoplastic Agents Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Anti-Neoplastic Agents Sales Market Share by Country in 2019
Figure 34. North America Anti-Neoplastic Agents Revenue Market Share by Country in 2019
Figure 35. U.S. Anti-Neoplastic Agents Sales Growth Rate (2015-2020) (K MT)
Figure 36. U.S. Anti-Neoplastic Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Anti-Neoplastic Agents Sales Growth Rate (2015-2020) (K MT)
Figure 38. Canada Anti-Neoplastic Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Anti-Neoplastic Agents Market Share by Type in 2019
Figure 40. North America Anti-Neoplastic Agents Market Share by Application in 2019
Figure 41. Europe Anti-Neoplastic Agents Sales Growth Rate 2015-2020 (K MT)
Figure 42. Europe Anti-Neoplastic Agents Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Anti-Neoplastic Agents Sales Market Share by Country in 2019
Figure 44. Europe Anti-Neoplastic Agents Revenue Market Share by Country in 2019
Figure 45. Germany Anti-Neoplastic Agents Sales Growth Rate (2015-2020) (K MT)
Figure 46. Germany Anti-Neoplastic Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Anti-Neoplastic Agents Sales Growth Rate (2015-2020) (K MT)
Figure 48. France Anti-Neoplastic Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Anti-Neoplastic Agents Sales Growth Rate (2015-2020) (K MT)
Figure 50. U.K. Anti-Neoplastic Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Anti-Neoplastic Agents Sales Growth Rate (2015-2020) (K MT)
Figure 52. Italy Anti-Neoplastic Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Anti-Neoplastic Agents Sales Growth Rate (2015-2020) (K MT)
Figure 54. Russia Anti-Neoplastic Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Anti-Neoplastic Agents Market Share by Type in 2019
Figure 56. Europe Anti-Neoplastic Agents Market Share by Application in 2019
Figure 57. Asia Pacific Anti-Neoplastic Agents Sales Growth Rate 2015-2020 (K MT)
Figure 58. Asia Pacific Anti-Neoplastic Agents Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Anti-Neoplastic Agents Sales Market Share by Region in 2019
Figure 60. Asia Pacific Anti-Neoplastic Agents Revenue Market Share by Region in 2019
Figure 61. China Anti-Neoplastic Agents Sales Growth Rate (2015-2020) (K MT)
Figure 62. China Anti-Neoplastic Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Anti-Neoplastic Agents Sales Growth Rate (2015-2020) (K MT)
Figure 64. Japan Anti-Neoplastic Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Anti-Neoplastic Agents Sales Growth Rate (2015-2020) (K MT)
Figure 66. South Korea Anti-Neoplastic Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Anti-Neoplastic Agents Sales Growth Rate (2015-2020) (K MT)
Figure 68. India Anti-Neoplastic Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Anti-Neoplastic Agents Sales Growth Rate (2015-2020) (K MT)
Figure 70. Australia Anti-Neoplastic Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Anti-Neoplastic Agents Sales Growth Rate (2015-2020) (K MT)
Figure 72. Taiwan Anti-Neoplastic Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Anti-Neoplastic Agents Sales Growth Rate (2015-2020) (K MT)
Figure 74. Indonesia Anti-Neoplastic Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Anti-Neoplastic Agents Sales Growth Rate (2015-2020) (K MT)
Figure 76. Thailand Anti-Neoplastic Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Anti-Neoplastic Agents Sales Growth Rate (2015-2020) (K MT)
Figure 78. Malaysia Anti-Neoplastic Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Anti-Neoplastic Agents Sales Growth Rate (2015-2020) (K MT)
Figure 80. Philippines Anti-Neoplastic Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Anti-Neoplastic Agents Sales Growth Rate (2015-2020) (K MT)
Figure 82. Vietnam Anti-Neoplastic Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Anti-Neoplastic Agents Market Share by Type in 2019
Figure 84. Asia Pacific Anti-Neoplastic Agents Market Share by Application in 2019
Figure 85. Latin America Anti-Neoplastic Agents Sales Growth Rate 2015-2020 (K MT)
Figure 86. Latin America Anti-Neoplastic Agents Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Anti-Neoplastic Agents Sales Market Share by Country in 2019
Figure 88. Latin America Anti-Neoplastic Agents Revenue Market Share by Country in 2019
Figure 89. Mexico Anti-Neoplastic Agents Sales Growth Rate (2015-2020) (K MT)
Figure 90. Mexico Anti-Neoplastic Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Anti-Neoplastic Agents Sales Growth Rate (2015-2020) (K MT)
Figure 92. Brazil Anti-Neoplastic Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Anti-Neoplastic Agents Sales Growth Rate (2015-2020) (K MT)
Figure 94. Argentina Anti-Neoplastic Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Anti-Neoplastic Agents Market Share by Type in 2019
Figure 96. Latin America Anti-Neoplastic Agents Market Share by Application in 2019
Figure 97. Middle East and Africa Anti-Neoplastic Agents Sales Growth Rate 2015-2020 (K MT)
Figure 98. Middle East and Africa Anti-Neoplastic Agents Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Anti-Neoplastic Agents Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Anti-Neoplastic Agents Revenue Market Share by Country in 2019
Figure 101. Turkey Anti-Neoplastic Agents Sales Growth Rate (2015-2020) (K MT)
Figure 102. Turkey Anti-Neoplastic Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Anti-Neoplastic Agents Sales Growth Rate (2015-2020) (K MT)
Figure 104. Saudi Arabia Anti-Neoplastic Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Anti-Neoplastic Agents Sales Growth Rate (2015-2020) (K MT)
Figure 106. U.A.E Anti-Neoplastic Agents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Anti-Neoplastic Agents Market Share by Type in 2019
Figure 108. Middle East and Africa Anti-Neoplastic Agents Market Share by Application in 2019
Figure 109. North America Anti-Neoplastic Agents Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 110. North America Anti-Neoplastic Agents Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Anti-Neoplastic Agents Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 112. Europe Anti-Neoplastic Agents Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Anti-Neoplastic Agents Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. Asia Pacific Anti-Neoplastic Agents Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Anti-Neoplastic Agents Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Latin America Anti-Neoplastic Agents Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Anti-Neoplastic Agents Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 118. Middle East and Africa Anti-Neoplastic Agents Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
固結防止剤の世界市場（～2026年） Anti-caking agents are utilized to prevent the formation of lumps, mostly in finely powdered substances. Anti-caking agents are soluble in alcohol, water and other organic solvents. They either absorb excess moisture or create a water-repellent coating on the powdered particles. Asia Pacific is expe…- 昆虫成長調節剤の世界市場（～2026年） Market Analysis and Insights: Global Anti-juvenile Hormone Agents Market The global Anti-juvenile Hormone Agents market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Anti-juvenile Hormone Agents Scope and Market Size Anti-j…
- 飼料固結防止剤の世界市場（～2026年） Market Analysis and Insights: Global Feed Anti-Caking Agents Market The global Feed Anti-Caking Agents market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Feed Anti-Caking Agents Scope and Market Size Feed Anti-Caking Agen…
- 抗感染症薬の世界市場（～2026年） Anti-infective agents are drugs used for the purpose of killing and/or suppressing the infection causing organisms from invading the host by means of its replication or releasing variety of toxins into the host. Infection causing micro-organisms include bacteria, viruses, fungi, viroids, and macro p…
- マイクロバブル/超音波造影剤の世界市場（～2026年） Microbubbles/ultrasound contrast agents are small spherical bubbles comprised of three phases, namely innermost gas phase, shell material enclosing the gas phase, and outermost gas or liquid phase. These microbubbles have unique ability to respond to ultrasound; thereby used for ultrasound imaging a…